Please login to the form below

Not currently logged in
Email:
Password:

Wyeth makes new hires

Wyeth makes two new appointments to its Women's Health Care Business Unit

The pharmaceutical division of Wyeth has appointed Cathy Kerzner to the position of senior vice-president and general manager of the company's Women's Health Care Business Unit.

Kerzner will lead the commercial aspects of Wyeth's portfolio of the unit's products on a global basis and will report to Joseph Mahady, president of global businesses of Wyeth Pharmaceuticals.

She had spent 14 years with Wyeth in a number of commercial capacities before advancing to the position of vice-president of business strategy and then vice-president of commercial strategy for Cardinal Health. Kerzner founded EKR Therapeutics, a US-based start-up specialty pharmaceutical company.

In addition, Wyeth has promoted Dr Michael Dey to the position of president of scientific affairs for women's health. Dey will focus on efforts to advance the understanding of the science that supports both new and existing female healthcare products at the firm. He will also report to Mahady.

Dey joined Wyeth-Ayerst R&D in 1984 and headed Wyeth's generic pharmaceutical business for eight years. Since 2001, he has served as president and general manager of the Women's Health Care arm.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics